Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.21.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.21.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
B.1.1.372EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.372EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.372ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.372ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.634EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.634EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.634ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.634ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.634EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.634EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.634ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.634ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.37.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.37.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.37.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.37.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.37.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.37.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.37.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.37.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.630EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.630EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.630ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.630ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.630EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.630EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.630ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.630ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.360EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used